We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

29 hedge funds and large institutions have $8.53M invested in ImmuCell in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

7% more funds holding

Funds holding: 27 → 29 (+2)

0.38% more ownership

Funds ownership: 12.29% → 12.67% (+0.38%)

0% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 6

7% less capital invested

Capital invested by funds: $9.18M → $8.53M (-$650K)

Holders
29
Holders Change
+2
Holders Change %
+7.41%
% of All Funds
0.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
6
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
CAM
Cresset Asset Management
Illinois
+$815K
2
BL
Bleichroeder LP
New York
+$265K
3
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$14.1K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$7.81K
5
BlackRock
BlackRock
New York
+$7.71K

Top Sellers

Rank Fund Capital Flow
1
OMC
Overbrook Management Corp
New York
-$89.7K
2
Koshinski Asset Management
Koshinski Asset Management
Illinois
-$13.5K
3
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
-$8.67K
4
Renaissance Technologies
Renaissance Technologies
New York
-$6.87K
5
Northern Trust
Northern Trust
Illinois
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.77M -$5.17K -596 -0.3%
Renaissance Technologies
2
Renaissance Technologies
New York
$1.34M -$6.87K -792 -0.5%
BL
3
Bleichroeder LP
New York
$883K +$265K +30,521 +43%
CAM
4
Cresset Asset Management
Illinois
$817K +$815K +94,019 New
SRC
5
Shufro Rose & Co
New York
$713K -$78 -9 -0%
Morgan Stanley
6
Morgan Stanley
New York
$580K – – –
PCM
7
Perritt Capital Management
Illinois
$317K – – –
OMC
8
Overbrook Management Corp
New York
$309K -$89.7K -10,344 -23%
SFS
9
Strategic Financial Services
New York
$269K – – –
Geode Capital Management
10
Geode Capital Management
Massachusetts
$204K +$7.81K +901 +4%
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$183K +$14.1K +1,623 +8%
HighTower Advisors
12
HighTower Advisors
Illinois
$159K – – –
FHA
13
Flagship Harbor Advisors
Massachusetts
$141K – – –
PP
14
Prosperity Planning
Missouri
$139K – – –
BlackRock
15
BlackRock
New York
$137K +$7.71K +889 +6%
WE
16
Wealth Effects
Massachusetts
$136K – – –
Northern Trust
17
Northern Trust
Illinois
$110K -$6K -692 -5%
MA
18
Minerva Advisors
Pennsylvania
$102K – – –
EFS
19
Essex Financial Services
Connecticut
$96K – – –
HPC
20
HM Payson & Co
Maine
$71K – – –
UBS Group
21
UBS Group
Switzerland
$23K +$5.91K +682 +35%
Bank of America
22
Bank of America
North Carolina
$17K – – –
TCWM
23
Total Clarity Wealth Management
Illinois
$6K +$6.08K +701 New
US Bancorp
24
US Bancorp
Minnesota
$5K – – –
CAPTRUST Financial Advisors
25
CAPTRUST Financial Advisors
North Carolina
$2K -$8.67K -1,000 -83%
1
2

ICCC Hedge Fund Activity: Q2 2022 in Review

29 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2022, worth a combined $8.53M — down 7.1% from $9.18M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ICCC positions and 1 closed out — a net gain of 3 holders — while 6 added to existing stakes and 6 trimmed.

The largest buyer was Cresset Asset Management, opening a new position worth an estimated $815K. The largest seller was Overbrook Management Corp, cutting an estimated $89.7K.

  • 29 institutional investors held ImmuCell (ICCC) as of Q2 2022, up from 27 in Q1 2022.
  • Funds reported $8.53M of ImmuCell stock for Q2 2022, down 7.1% quarter-over-quarter.
  • 4 funds opened new ImmuCell positions in Q2 2022 and 1 closed out, a net change of +3 holders.
  • The largest ImmuCell buyer in Q2 2022 was Cresset Asset Management, an estimated $815K added.
  • The largest ImmuCell seller in Q2 2022 was Overbrook Management Corp, an estimated $89.7K sold.

Based on aggregated 13F filings for Q2 2022.